Treatment of Childhood-onset Proliferative Lupus Nephritis in the 21st Century: A Call to Catch Up With the Evidence

Q2 Medicine

The Journal of rheumatology. Supplement Pub Date : 2022-04-01 DOI:10.3899/jrheum.220196

D. Noone, E. Silverman

引用次数: 0

Abstract

Proliferative lupus nephritis (PLN) is associated with significant morbidity, mortality, and kidney failure, especially in childhood-onset PLN (cPLN). Therefore, it is important to treat it promptly and aggressively, while being cognizant of the risk-benefit ratio and side effects of therapies.

查看原文本刊更多论文

21世纪儿童性增殖性狼疮性肾炎的治疗:追赶证据的呼唤

增殖性狼疮性肾炎(PLN)与显著的发病率、死亡率和肾衰竭相关，特别是在儿童期发作的PLN (cPLN)。因此，及时和积极地治疗是很重要的，同时要认识到治疗的风险-收益比和副作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of rheumatology. Supplement Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Duncan A. Gordon, The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 36 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.